Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HR 568Session 2025-2026

A Resolution designating June 23, 2026, as "Dravet Syndrome Awareness Day" in Pennsylvania.

Printer's No. PN3605

See other bills
under the
same topic PRINTER'S NO. 3605 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.568 Session of 2026 INTRODUCED BY McANDREW, HARKINS, McNEILL, WAXMAN, SANCHEZ, RIVERA, GUZMAN, PROBST, NEILSON, VENKAT, DEASY, HADDOCK AND STEELE, JUNE 15, 2026 REFERRED TO COMMITTEE ON HEALTH, JUNE 15, 2026 A RESOLUTIONDesignating June 23, 2026, as "Dravet Syndrome Awareness Day" in Pennsylvania.WHEREAS, Dravet syndrome, formerly referred to as severe myoclonic epilepsy of infancy, is a genetic form of epilepsy that is characterized by temperature-sensitive seizures; andWHEREAS, These temperature-sensitive seizures, also referred to as febrile seizures, usually begin when an infant is between four months and twelve months of age and may manifest as grand mal seizures that involve convulsive movements of the entire body; andWHEREAS, Many infants with Dravet syndrome first experience a hemiclonic seizure where jerking movements only affect one side of the body, and the seizures are unlikely to stop on their own and can occur in clusters; andWHEREAS, After their first febrile seizure, the presence of a fever is unnecessary for another to occur, and future seizures could be triggered by any slight change in body temperature; and1234567891011121314151617 WHEREAS, Before the onset of these seizures, infants with Dravet syndrome reach their developmental milestones in time, but when seizures begin, the infants begin to exhibit developmental delays and features of autism spectrum disorder; andWHEREAS, In addition to seizures, patients with Dravet syndrome may experience severe intellectual and developmental disabilities, motor and speech impairments, behavioral difficulties and sleep abnormalities; andWHEREAS, Diagnosis of Dravet syndrome can be delayed and often requires expensive genetic testing because electroencephalogram and magnetic resonance imaging tests often produce normal results when seizures first appear; andWHEREAS, Genetic testing looks for a pathogenic variant in the SCN1A gene, which can impair the flow of sodium ions into brain neurons to lead to an overactivity of neurons that causes the seizures and epilepsy, but only 90% of children with Dravet syndrome have a mutated SCN1A gene, further complicating diagnosis; andWHEREAS, Dravet syndrome is treated by reducing or eliminating seizures through the use of anticonvulsant drugs and purified forms of cannabidiol that have been approved by the United States Food and Drug Administration, dietary therapy and vagus nerve stimulation in situations where medications are ineffective in controlling seizures; andWHEREAS, Treatment for Dravet syndrome is often also paired with family counseling and support, physical therapy, occupational therapy and speech therapy; andWHEREAS, Dravet syndrome is a rare condition, estimated to affect approximately 20,000 people in the United States, with 20260HR0568PN3605 - 2 - 123456789101112131415161718192021222324252627282930 only 1 in 16,000 babies being born with it; andWHEREAS, Patients with Dravet syndrome face a 15% to 20% mortality rate due to sudden unexpected death in epilepsy, prolonged seizures, seizure-related accidents and infections; andWHEREAS, The Dravet Syndrome Foundation has recognized the Epilepsy Neurogenetics Initiative at the Children's Hospital of Philadelphia, or CHOP, as a Dravet Comprehensive Care Center to acknowledge the expertise of CHOP providers in providing comprehensive care for children living with Dravet syndrome; andWHEREAS, Pennsylvania should take pride in having a Dravet Comprehensive Care Center in our State and in the hardworking physicians and medical professionals that have dedicated their lives and careers to helping children with this genetic neurological condition; andWHEREAS, "Dravet Syndrome Awareness Month" takes place each June in the United States, and "International Dravet Syndrome Awareness Day" is observed on June 23; andWHEREAS, The Dravet Syndrome Foundation is recognizing all those that have been lost to this condition on the sixth annual remembrance day held on June 15, 2026; therefore be itRESOLVED, That the House of Representatives designate June 23, 2026, as "Dravet Syndrome Awareness Day" in Pennsylvania.20260HR0568PN3605 - 3 - 1234567891011121314151617181920212223

Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.